Fulgent Genetics Revenue 2015-2024 | FLGT
Fulgent Genetics revenue from 2015 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Fulgent Genetics Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $289 |
| 2022 | $619 |
| 2021 | $993 |
| 2020 | $422 |
| 2019 | $33 |
| 2018 | $21 |
| 2017 | $19 |
| 2016 | $18 |
| 2015 | $10 |
| 2014 | $1 |
| Fulgent Genetics Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-09-30 | $72 |
| 2024-06-30 | $71 |
| 2024-03-31 | $64 |
| 2023-12-31 | $71 |
| 2023-09-30 | $85 |
| 2023-06-30 | $68 |
| 2023-03-31 | $66 |
| 2022-12-31 | $68 |
| 2022-09-30 | $106 |
| 2022-06-30 | $125 |
| 2022-03-31 | $320 |
| 2021-12-31 | $252 |
| 2021-09-30 | $228 |
| 2021-06-30 | $154 |
| 2021-03-31 | $359 |
| 2020-12-31 | $295 |
| 2020-09-30 | $102 |
| 2020-06-30 | $17 |
| 2020-03-31 | $8 |
| 2019-12-31 | $8 |
| 2019-09-30 | $10 |
| 2019-06-30 | $8 |
| 2019-03-31 | $5 |
| 2018-12-31 | $6 |
| 2018-09-30 | $6 |
| 2018-06-30 | $5 |
| 2018-03-31 | $5 |
| 2017-12-31 | $4 |
| 2017-09-30 | $5 |
| 2017-06-30 | $5 |
| 2017-03-31 | $5 |
| 2016-12-31 | $6 |
| 2016-09-30 | $5 |
| 2016-06-30 | $4 |
| 2016-03-31 | $3 |
| 2015-12-31 | |
| 2015-09-30 | $3 |
| 2015-06-30 | |
| 2014-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.518B | $0.289B |
| Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $8.263B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.580B | 174.01 |
| Hims & Hers Health (HIMS) | United States | $5.276B | 134.17 |
| Enovis (ENOV) | United States | $2.580B | 17.49 |
| Privia Health (PRVA) | United States | $2.530B | 210.80 |
| IRhythm Technologies (IRTC) | United States | $2.313B | 0.00 |
| Azenta (AZTA) | United States | $2.227B | 111.05 |
| Omnicell (OMCL) | United States | $2.043B | 66.83 |
| Clover Health Investments (CLOV) | United States | $1.684B | 0.00 |
| 10x Genomics (TXG) | United States | $1.609B | 0.00 |
| Schrodinger (SDGR) | United States | $1.484B | 0.00 |
| Phreesia (PHR) | United States | $1.098B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.701B | 0.00 |
| Standard BioTools (LAB) | United States | $0.603B | 0.00 |
| Talkspace (TALK) | United States | $0.559B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.491B | 85.00 |
| Health Catalyst (HCAT) | United States | $0.466B | 0.00 |
| Pulmonx (LUNG) | United States | $0.254B | 0.00 |
| TruBridge (TBRG) | United States | $0.239B | 69.61 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.205B | 0.00 |
| American Well (AMWL) | United States | $0.123B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.115B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.077B | 0.00 |
| HeartBeam (BEAT) | United States | $0.075B | 0.00 |
| 111 (YI) | China | $0.052B | 0.00 |
| CareCloud (CCLD) | United States | $0.046B | 0.00 |
| Outset Medical (OM) | United States | $0.040B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.040B | 0.00 |
| Zepp Health (ZEPP) | China | $0.038B | 0.00 |
| Movano (MOVE) | United States | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.010B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |